Medicine and Dentistry
Ablation Therapy
5%
All Cause Mortality
5%
Arrhythmia
9%
Atrial Fibrillation
9%
Atrioventricular Node
9%
Bradycardia
9%
Breathing Mechanics
5%
Calcium Calmodulin Dependent Protein Kinase II
29%
Calcium Ion
29%
Cardiac Dysrhythmia
29%
Cardiac Magnetic Resonance Imaging
24%
Cardiac Resynchronization Therapy
29%
Cardiomyopathy
53%
Cardiovascular Disease
29%
Cardiovascular System
29%
Catheter Ablation
64%
Disease
29%
Diseases
9%
Electromagnetic Field
5%
Electrophysiology
29%
Energy Transfer
9%
Epicardial Fat
29%
Fluoroscopy
29%
Gadolinium
29%
Health Care
9%
Heart Cycle
9%
Heart Failure
31%
Heart Innervation
29%
Heart Left Ventricle Ejection Fraction
10%
Implantable Automatic Defibrillator
29%
In Vitro
29%
Lid Margin Neovascularized Area
29%
Low and Middle Income Countries
9%
Magnetic Resonance Imaging
29%
Magnetic Resonance Imaging
9%
Mortality Rate
9%
Multidetector Computed Tomography
29%
Myocardium
15%
Positron Emission Tomography
29%
Prematurity
9%
Radioactive Tracer
11%
Signal Analysis
8%
Sinoatrial Node
9%
Sudden Cardiac Death
9%
Sudden Death
29%
Survival Analysis
5%
Transferase
29%
Transgenic Mouse
14%
Treatment Response
8%
Ventricular Tachycardia
100%
Keyphrases
18-fluorodeoxyglucose
22%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
29%
All-cause Mortality
7%
Area Size
7%
Atrial Fibrillation
29%
Biplane Fluoroscopy
14%
CaMKII
58%
Cardiac Innervation
29%
Cardiomyopathy
9%
Cardiovascular Disease
29%
CARTO
29%
Diabetic
8%
Diabetic Mice
29%
Digital Training
9%
Distinct Mechanism
29%
Electroanatomic Mapping System
29%
Electroanatomic Navigation System
29%
Fat Mapping
29%
Heart Failure Death
29%
High Mortality
7%
Innervation Imaging
29%
LMNA Cardiomyopathy
29%
Location Estimation
14%
Location Estimation Error
29%
Metabolic
31%
Multivariable
7%
Myocardium
9%
Non-ischemic
7%
Novel Paradigm
29%
O-GlcNAc Transferase
14%
O-GlcNAcase
17%
O-GlcNAcylation
58%
Pathologic
7%
Perfusion
22%
Positron Emission Tomography Study
7%
Postablation
29%
Predictive Value
7%
Risk Management
7%
Risk Stratification
7%
Scar
7%
Substrate Ablation
29%
Successful Ablation
29%
Sudden Death
29%
Survival Analysis
7%
Therapeutic Target
29%
Transgenic
9%
Ventricular Tachycardia
29%
Ventricular Tachycardia Ablation
7%
Viability Study
14%
Zone Diameter
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
5%
All Cause Mortality
29%
Atrial Fibrillation
61%
Atrioventricular Block
5%
Calcium Calmodulin Dependent Protein Kinase II
88%
Calcium Ion
36%
Cardiomyopathy
61%
Cardiovascular Disease
29%
Casein Kinase
7%
Diabetes Mellitus
29%
Disease
32%
Event Free Survival
5%
Gadolinium
29%
Heart Arrhythmia
8%
Heart Atrium Remodeling
29%
Heart Failure
35%
Heart Ventricle Arrhythmia
34%
Heart Ventricle Tachycardia
15%
Human Study
7%
Implant
5%
Infarction
19%
Inflammation
7%
Mouse
38%
Mouse Model
7%
Observational Study
5%
Prematurity
9%
Ruxolitinib
29%
Sudden Death
29%
Transferase
29%
Transgenic Mouse
14%